{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T11:18:00Z","timestamp":1753183080265},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,10,31]],"date-time":"2010-10-31T00:00:00Z","timestamp":1288483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00417-010-1548-x","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T16:14:04Z","timestamp":1288714444000},"page":"273-280","source":"Crossref","is-referenced-by-count":6,"title":["Focal macular electroretinograms after photodynamic therapy combined with intravitreal bevacizumab"],"prefix":"10.1007","volume":"249","author":[{"given":"Kohei","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hua","family":"Piao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineo","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,31]]},"reference":[{"key":"1548_CR1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group","year":"1999","unstructured":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report 1. Arch Ophthalmol 117:1329\u20131345","journal-title":"Arch Ophthalmol"},{"key":"1548_CR2","first-page":"198","volume":"119","author":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group","year":"2001","unstructured":"Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of two randomized clinical trials-TAP report 2. Arch Ophthalmol 119:198\u2013207","journal-title":"Arch Ophthalmol"},{"key":"1548_CR3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0161-6420(01)00544-9","volume":"108","author":"Verteporfin in Photodynamic Therapy Study Group","year":"2001","unstructured":"Verteporfin in Photodynamic Therapy Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial. VIP report 1. Ophthalmology 108:841\u2013852","journal-title":"Ophthalmology"},{"key":"1548_CR4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9394(01)00967-9","volume":"131","author":"Verteporfin in Photodynamic Therapy Study Group","year":"2001","unstructured":"Verteporfin in Photodynamic Therapy Study Group (2001) Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization: verteporfin in photodynamic therapy report 2. Am J Ophthalmol 131:541\u2013560","journal-title":"Am J Ophthalmol"},{"key":"1548_CR5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0002-9394(03)00576-2","volume":"136","author":"Japanese Age-Related Macular Degeneration Trial (JAT) Study Group","year":"2003","unstructured":"Japanese Age-Related Macular Degeneration Trial (JAT) Study Group (2003) Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol 136:1049\u20131061","journal-title":"Am J Ophthalmol"},{"key":"1548_CR6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00006982-200502000-00002","volume":"25","author":"Verteporfin Roundtable Participants","year":"2005","unstructured":"Verteporfin Roundtable Participants (2005) Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina 25:119\u2013134","journal-title":"Retina"},{"key":"1548_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/112067210301300507","volume":"13","author":"MN Moschos","year":"2003","unstructured":"Moschos MN, Panayotidis D, Moschos MM, Bouros C, Theodossiadis PG, Theodossiadis GP (2003) A preliminary assessment of macular function by MF-ERG in myopic eyes with CNV with complete response to photodynamic therapy. Eur J Ophthalmol 13:461\u2013467","journal-title":"Eur J Ophthalmol"},{"key":"1548_CR8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00347-002-0757-z","volume":"100","author":"K R\u00fcther","year":"2003","unstructured":"R\u00fcther K, Breidenbach K, Schwartz R, Hassenstein A, Richard G (2003) Testing central retinal function with multifocal electroretinography before and after photodynamic therapy. Ophthalmologe 100:459\u2013464","journal-title":"Ophthalmologe"},{"key":"1548_CR9","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ajo.2003.11.079","volume":"137","author":"TY Lai","year":"2004","unstructured":"Lai TY, Chan WM, Lam DS (2004) Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol 137:826\u2013833","journal-title":"Am J Ophthalmol"},{"key":"1548_CR10","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1167\/iovs.06-1277","volume":"48","author":"K Ishikawa","year":"2007","unstructured":"Ishikawa K, Kondo M, Ito Y, Kikuchi M, Nishihara H, Piao CH, Sugita T, Terasaki H (2007) Correlation between focal macular electroretinograms and angiographic findings after photodynamic therapy. Investig Ophthalmol Vis Sci 48:2254\u20132259","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1548_CR11","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.ophtha.2005.06.018","volume":"112","author":"A Moere Van de","year":"2005","unstructured":"Van de Moere A, Sandhu SS, Kak R, Mitchell KW, Talks SJ (2005) Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin. Ophthalmology 112:1896\u20131903","journal-title":"Ophthalmology"},{"key":"1548_CR12","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0161-6420(03)00544-X","volume":"110","author":"RF Spaide","year":"2003","unstructured":"Spaide RF, Sorenson J, Maranan L (2003) Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110:1517\u20131525","journal-title":"Ophthalmology"},{"key":"1548_CR13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ophtha.2004.08.012","volume":"112","author":"RF Spaide","year":"2005","unstructured":"Spaide RF, Sorenson J, Maranan L (2005) Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112:301\u2013304","journal-title":"Ophthalmology"},{"key":"1548_CR14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bjo.2003.027177","volume":"88","author":"E Rechtman","year":"2004","unstructured":"Rechtman E, Danis RP, Pratt LM, Harris A (2004) Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularization in age related macular degeneration. Br J Ophthalmol 88:344\u2013347","journal-title":"Br J Ophthalmol"},{"key":"1548_CR15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/bjo.2005.081299","volume":"90","author":"WM Chan","year":"2006","unstructured":"Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS (2006) Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularization in age related macular degeneration. A comparative study. Br J Ophthalmol 90:337\u2013341","journal-title":"Br J Ophthalmol"},{"key":"1548_CR16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00417-005-0155-8","volume":"244","author":"I Krebs","year":"2006","unstructured":"Krebs I, Binder S, Stolba U (2006) A new treatment regimen in\u3000combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 244:863\u2013867","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1548_CR17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00006982-200601000-00010","volume":"26","author":"M Nicol\u00f2","year":"2006","unstructured":"Nicol\u00f2 M, Ghiglione D, Lai S, Nasciuti F, Cicinelli S, Calabria G (2006) Occult with no classic choroidal neovascularization secondary to age related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Retina 26:58\u201364","journal-title":"Retina"},{"key":"1548_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2005.09.002","volume":"113","author":"AJ Augustin","year":"2006","unstructured":"Augustin AJ, Schmidt-Erfurth U (2006) Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age related macular degeneration. Ophthalmology 113:14\u201322","journal-title":"Ophthalmology"},{"key":"1548_CR19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00006982-200607000-00003","volume":"26","author":"JM Ruiz-Moreno","year":"2006","unstructured":"Ruiz-Moreno JM, Montero J, Barile S, Zarbin M (2006) Photodynamic therapy and high-dose intravitreal triamcinolone to\u3000treat exudative age-related macular degeneration: 1-year outcome. Retina 26:602\u2013612","journal-title":"Retina"},{"key":"1548_CR20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/112067210601600311","volume":"16","author":"JM Ruiz-Moreno","year":"2006","unstructured":"Ruiz-Moreno JM, Montero J, Barile S (2006) Triamcinolone and PDT to treat exudative age-related macular degeneration and submacular hemorrhage. Eur J Ophthalmol 16:426\u2013434","journal-title":"Eur J Ophthalmol"},{"key":"1548_CR21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ajo.2005.11.058","volume":"141","author":"AJ Augustin","year":"2006","unstructured":"Augustin AJ, Schmidt-Erfurth U (2006) Verteporfin and intravitreal\u3000triamcinolone acetonide combination therapy for occult choroidal neovascularization in age related macular\u3000degeneration. Am J Ophthalmol 141:638\u2013645","journal-title":"Am J Ophthalmol"},{"key":"1548_CR22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/IAE.0b013e31819c631a","volume":"29","author":"K Ishikawa","year":"2009","unstructured":"Ishikawa K, Nishihara H, Ozawa S, Piao CH, Ito Y, Kondo M, Terasaki H (2009) Focal macular electroretinograms after photodynamic therapy combined with posterior juxtascleral triamcinolone acetonide. Retina 29:803\u2013810","journal-title":"Retina"},{"key":"1548_CR23","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1167\/iovs.02-1115","volume":"44","author":"U Schmidt-Erfurth","year":"2003","unstructured":"Schmidt-Erfurth U, Schl\u00f6tzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GO (2003) Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Investig Ophthalmol Vis Sci 44:4473\u20134480","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1548_CR24","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00417-007-0557-x","volume":"245","author":"R Jorge","year":"2007","unstructured":"Jorge R, Costa RA, Calucci D, Scott IU (2007) Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study). Graefes Arch Clin Exp Ophthalmol 245:1273\u20131280","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1548_CR25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/IAE.0b013e31816b316e","volume":"28","author":"BT Smith","year":"2008","unstructured":"Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr, Mittra RA (2008) Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in aged-related macular degeneration. Retina 28:675\u2013681","journal-title":"Retina"},{"key":"1548_CR26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/bjo.2007.125823","volume":"92","author":"G Weigert","year":"2008","unstructured":"Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U (2008) Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomized, controlled clinical study. Br J Ophthalmol 92:356\u2013360","journal-title":"Br J Ophthalmol"},{"key":"1548_CR27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00417-007-0654-x","volume":"246","author":"MS Ladewig","year":"2008","unstructured":"Ladewig MS, Karl SE, Hamelmann V, Helb HM, Scholl HP, Holz FG, Eter N (2008) Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 246:17\u201325","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1548_CR28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10633-009-9166-9","volume":"119","author":"C Zuo","year":"2009","unstructured":"Zuo C, Wen F, Li J, Liu Y, Li M (2009) Transitions of multifocal electroretinography following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy. Doc Ophthalmol 119:29\u201336","journal-title":"Doc Ophthalmol"},{"key":"1548_CR29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","volume":"113","author":"RL Avery","year":"2006","unstructured":"Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363\u2013372","journal-title":"Ophthalmology"},{"key":"1548_CR30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00006982-200604000-00001","volume":"26","author":"RF Spaide","year":"2006","unstructured":"Spaide RF, Laud K, Fine HF, Klancnik JM Jr, Meyerle CB, Yannuzzi LA, Sorenson J, Slakter J, Fisher YL, Cooney MJ (2006) Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26:383\u2013390","journal-title":"Retina"},{"key":"1548_CR31","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1167\/iovs.06-0433","volume":"47","author":"RA Costa","year":"2006","unstructured":"Costa RA, Jorge R, Calucci D, Cardillo JA, Melo LA Jr, Scott IU (2006) Intravitreal bevacizumab (Avastin) for choroidal neovascularization caused by age-related macular degeneration (IBeNA Study): results of a dose-escalation study. Investig Ophthalmol Vis Sci 47:4569\u20134578","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1548_CR32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","volume":"26","author":"D Iturralde","year":"2006","unstructured":"Iturralde D, Spaide RF, Meyerle CB, Klancnik JM, Yannuzzi LA, Fisher YL, Sorenson J, Slakter JS, Freund KB, Cooney M, Fine HF (2006) Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26:279\u2013284","journal-title":"Retina"},{"key":"1548_CR33","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ajo.2007.03.007","volume":"143","author":"S Peters","year":"2007","unstructured":"Peters S, Heiduschka P, Julien S, Ziemssen F, Fietz H, Bartz-Schmidt KU, T\u00fcbingen Bevacizumab Study Group, Schraermeyer U (2007) Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 143:995\u20131002","journal-title":"Am J Ophthalmol"},{"key":"1548_CR34","first-page":"1631","volume":"29","author":"Y Miyake","year":"1988","unstructured":"Miyake Y, Shiroyama N, Ota I, Horiguchi M (1988) Oscillatory potentials in electroretinograms of the human macular region. Investig Ophthalmol Vis Sci 29:1631\u20131635","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1548_CR35","first-page":"1419","volume":"92","author":"Y Miyake","year":"1988","unstructured":"Miyake Y (1988) Studies of local macular ERG. Acta Soc Ophthalmol Jpn 92:1419\u20131449","journal-title":"Acta Soc Ophthalmol Jpn"},{"key":"1548_CR36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10384-008-0528-8","volume":"52","author":"K Ishikawa","year":"2008","unstructured":"Ishikawa K, Ito Y, Mizutani R, Kikuchi M, Nishihara H, Terasaki H (2008) New computer program to analyze OCT images of fovea quantitatively before and after photodynamic therapy. Jpn J Ophthalmol 52:182\u2013189","journal-title":"Jpn J Ophthalmol"},{"key":"1548_CR37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/IAE.0b013e3181bcedbe","volume":"30","author":"Y Hatta","year":"2010","unstructured":"Hatta Y, Ishikawa K, Nishihara H, Ozawa S, Ito Y, Terasaki H (2010) Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal perfusion. Retina 30:495\u2013502","journal-title":"Retina"},{"key":"1548_CR38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/bjo.2006.098004","volume":"91","author":"R Obata","year":"2007","unstructured":"Obata R, Iriyama A, Inoue Y, Takahashi H, Tamaki Y, Yanagi Y (2007) Triamcinolone acetonide suppresses early proangiogenic response in RPE cells after photodynamic therapy in vitro. Br J Ophthalmol 91:100\u2013104","journal-title":"Br J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1548-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-010-1548-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1548-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T12:59:10Z","timestamp":1592053150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-010-1548-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,31]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1548"],"URL":"https:\/\/doi.org\/10.1007\/s00417-010-1548-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,31]]}}}